Skip to content

CapEx at other companies

Pfizer logo
PfizerPFE
$436M-22.7%
Gilead Sciences logo
Gilead SciencesGILD
$117M+12.5%
Regenxbio logo
RegenxbioRGNX
$1.24M+20.6%
Xencor logo
XencorXNCR
$610K-57.8%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$17K-51.4%
Schrodinger logo
SchrodingerSDGR
$2.51M+321%

Other financials

Income statement

See full
Revenue$14.5M-16.5%
Operating income-$29.7M+56.7%
Net income-$38.5M+49.3%
EPS (diluted)-$2.94+67.6%

Balance sheet

See full
Cash & equivalents$73.7M-30.6%
Total debt$13.6M-36.3%
Total equity-$66.9M-159%
Total assets$242.0M-24.7%

Cash flow

See full
Operating cash flow-$42.3M+37.7%
Free cash flow-$42.3M+37.8%

Valuation

See full
Market cap$489.66M+624%
Enterprise value$429.61M-2,600%
P/S4.9×+3.9×

Profitability

See full
Operating margin-120%-48.6pp
Net margin-154.2%-56.7pp
FCF margin-152.2%-51.1pp

Returns & leverage

See full
Return on equity-234.2%
Debt / equity0.5×+0.3×
Current ratio3.1×+1.0×

Where this comes from

Reported directly by Sutro Biopharma in its filing.

Tagged under the XBRL concept us-gaap:CapitalExpendituresIncurredButNotYetPaid.

The official record: Sutro Biopharma’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sutro Biopharma's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sutro Biopharma's capex?
Sutro Biopharma (STRO) reported capex of $0 in Q1 2026.
How has Sutro Biopharma's capex changed year-over-year?
Sutro Biopharma's capex decreased by 100.0% year-over-year, from $27K to $0.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.